Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
got off schedule with their 2nd dose due to COVID; This non-serious case was reported by a physician via call center representative and described the occurrence of social problem in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Patients received their first dose during COVID on an unknown date). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced social problem (Verbatim: got off schedule with their 2nd dose due to COVID). The outcome of the social problem was unknown. Additional Information: GSK Receipt Date: 31-JAN-2025 Reporter stated that 3 patients got their 1st Shingrix dose during COVID and got off schedule with their 2nd dose due to that, she then stated it was 1 or 2 patients.